GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » Float Percentage Of Total Shares Outstanding

BioGend Therapeutics Co (ROCO:6733) Float Percentage Of Total Shares Outstanding : 0.00% (As of Sep. 22, 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioGend Therapeutics Co Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BioGend Therapeutics Co's float shares is 0.00 Mil. BioGend Therapeutics Co's total shares outstanding is 124.26 Mil. BioGend Therapeutics Co's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BioGend Therapeutics Co's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BioGend Therapeutics Co's Institutional Ownership is 0.08%.


BioGend Therapeutics Co Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

BioGend Therapeutics Co's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/124.26
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioGend Therapeutics Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
4th Floor, Number 3, Park Street, Nangang District, Taipei, TWN, 115
BioGend Therapeutics Co Ltd is a Taiwan based company involved in developing regenerative bio-orthopaedic medicine to advance the clinical science of maintaining healthy joints in skeletal system. The Company is primarily engaged in the research and development of bone medical device related products. Its products under development include Big-001, Big-006 and Big-009.

BioGend Therapeutics Co Headlines

No Headlines